TAK-007

· Takeda

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAK-007, covering 2025-04-06 to 2025-08-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) [Phase 2]